RT001 in Progressive Supranuclear Palsy-Clinical and In-Vitro ObservationsANTIOXIDANTSIF6.62021-06-2512OAAI
Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in PatientsJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82020-11-0118PREAI
The infantile neuroaxonal dystrophy rating scale (INAD-RS)ORPHANET JOURNAL OF RARE DISEASESIF3.52020-07-298OAAI
The natural history of infantile neuroaxonal dystrophyORPHANET JOURNAL OF RARE DISEASESIF3.52020-05-0118OAAI
Only 20-25% Deuteration of Polyunsaturated Fatty Acids Prevents Lipid PeroxidationTrends in Molecular MedicineIF13.82020-04-011PREAI
Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney DiseaseTHROMBOSIS AND HAEMOSTASISIF4.32017-11-3016PREAI
Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulantTHROMBOSIS AND HAEMOSTASISIF4.32017-11-2812PREAI
A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin The EmbraceAC TrialTHROMBOSIS AND HAEMOSTASISIF4.32017-11-098PREAI
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trialINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22012-05-014PREAI
5-Year Follow-Up of Polytetrafluoroethylene-Covered Stents Compared With Bare-Metal Stents in Aortocoronary Saphenous Vein Grafts The Randomized BARRICADE (Barrier Approach to Restenosis: Restrict Intima to Curtail Adverse Events) TrialJACC-CARDIOVASCULAR INTERVENTIONSIF11.42011-03-0145OAAI
Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III TrialCIRCULATIONIF38.62009-02-10263OAAI
Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO studyPOSTGRADUATE MEDICAL JOURNALIF2.72006-06-0553OAAI
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions - Angiographic follow-up of the DELIVER clinical trialCIRCULATIONIF38.62004-04-27170OAAI
Analysis of 1-year clinical outcomes in the SIRIUS trial - A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosisCIRCULATIONIF38.62004-02-10470PREAI
A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous,transluminal under coronary angioplasty: The ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) studyAMERICAN HEART JOURNALIF3.52003-07-01106PREAI